Hoozemans JJ - Search Results

1

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD. Moors TE, et al. Among authors: hoozemans jj. Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3. Mol Neurodegener. 2017. PMID: 28122627 Free PMC article. Review.

2

Morphometric changes in the cortical microvascular network in Alzheimer's disease.

Richard E, van Gool WA, Hoozemans JJ, van Haastert ES, Eikelenboom P, Rozemuller AJ, van de Berg WD. Richard E, et al. Among authors: hoozemans jj. J Alzheimers Dis. 2010;22(3):811-8. doi: 10.3233/JAD-2010-100849. J Alzheimers Dis. 2010. PMID: 20858968

3

Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease.

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W. Hoozemans JJ, et al. Neurodegener Dis. 2012;10(1-4):212-5. doi: 10.1159/000334536. Epub 2012 Feb 1. Neurodegener Dis. 2012. PMID: 22302012 Review.

4

The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.

Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M, Walter J, Kumar S, van der Lee SJ, Holstege H, Zhu X, Van Nostrand WE, Natté R, van der Weerd L, Bouwman FH, van de Berg WDJ, Rozemuller AJM, Hoozemans JJM. Boon BDC, et al. Acta Neuropathol. 2020 Dec;140(6):811-830. doi: 10.1007/s00401-020-02198-8. Epub 2020 Sep 14. Acta Neuropathol. 2020. PMID: 32926214 Free PMC article.

5

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease.

Frigerio I, Boon BDC, Lin CP, Galis-de Graaf Y, Bol J, Preziosa P, Twisk J, Barkhof F, Hoozemans JJM, Bouwman FH, Rozemuller AJM, van de Berg WDJ, Jonkman LE. Frigerio I, et al. Brain Commun. 2021 Nov 24;3(4):fcab281. doi: 10.1093/braincomms/fcab281. eCollection 2021. Brain Commun. 2021. PMID: 34927073 Free PMC article.

6

Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.

van der Gaag BL, Deshayes NAC, Breve JJP, Bol JGJM, Jonker AJ, Hoozemans JJM, Courade JP, van de Berg WDJ. van der Gaag BL, et al. Among authors: hoozemans jjm. Acta Neuropathol. 2024 Jan 10;147(1):14. doi: 10.1007/s00401-023-02657-y. Acta Neuropathol. 2024. PMID: 38198008 Free PMC article.

7

Neuroinflammation and Alzheimer disease: clinical and therapeutic implications.

Eikelenboom P, Rozemuller AJ, Hoozemans JJ, Veerhuis R, van Gool WA. Eikelenboom P, et al. Among authors: hoozemans jj. Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S54-61. doi: 10.1097/00002093-200000001-00009. Alzheimer Dis Assoc Disord. 2000. PMID: 10850731 Review.

8

Immunological aspects of alzheimer's disease: therapeutic implications.

Hoozemans JJ, Rozemuller AJ, Veerhuis R, Eikelenboom P. Hoozemans JJ, et al. BioDrugs. 2001;15(5):325-37. doi: 10.2165/00063030-200115050-00004. BioDrugs. 2001. PMID: 11437695 Review.

9

The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications.

Hoozemans JJ, Veerhuis R, Rozemuller AJ, Eikelenboom P. Hoozemans JJ, et al. Drugs Today (Barc). 2002 Jun;38(6):429-43. doi: 10.1358/dot.2002.38.6.678350. Drugs Today (Barc). 2002. PMID: 12532179 Review.

10

Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.

Hoozemans JJ, Veerhuis R, Rozemuller AJ, Eikelenboom P. Hoozemans JJ, et al. Curr Drug Targets. 2003 Aug;4(6):461-8. doi: 10.2174/1389450033490902. Curr Drug Targets. 2003. PMID: 12866660 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page